Open AccessP509: CLONAL HEMATOPOIESIS‐ASSOCIATED MUTATIONS AS MEASURABLE RESIDUAL DISEASE MARKERS IN ACUTE MYELOID LEUKEMIA PATIENTS FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION
Author(s) -
Bischof L.,
Ussmann J.,
Brauer D.,
Backhaus D.,
Herrmann L.,
Franke G.N.,
Vucinic V.,
Metzeler K. H.,
Platzbecker U.,
Schwind S.,
Jentzsch M.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844924.32286.18
Subject(s) - medicine , myeloid leukemia , hematopoietic stem cell transplantation , minimal residual disease , transplantation , haematopoiesis , stem cell , myeloid , leukemia , bone marrow , idh2 , gastroenterology , oncology , immunology , mutation , biology , idh1 , genetics , biochemistry , gene